{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidahkw26fx274ux5unrq7snpva45rxq7qxrvzbdtokegnioluxy3m",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhy2nophfo62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaoga4yah7xlqrxnme5uynjomcrpx2x6n7sbd6bioqby3les7llh4"
    },
    "mimeType": "image/jpeg",
    "size": 797018
  },
  "path": "/news/2026-03-decade-early-stage-drug-shifted.html",
  "publishedAt": "2026-03-26T11:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research described by Georgetown University health policy experts.",
  "title": "Over the past decade, early-stage drug innovation has shifted toward China, researchers find"
}